Listen: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals

Does the Theranos trial actually matter? Is the FDA coming unglued? And what can prescription data tell us about America?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Former Theranos CEO Elizabeth Holmes is finally headed to trial, and we discuss the case and why it might not be an open-and-shut conviction for prosecutors. Then, STAT Washington correspondent Nicholas Florko joins us to explain the latest upheaval at the FDA, which arrives just as the agency faces mounting pressure to speed up the review of Covid-19 vaccines. We also discuss the race to develop antivirals for SARS-CoV-2 and why the eyelash-growth business is booming.

Read the rest…

Listen: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top